Studies heat ablation and an AI model for small papillary thyroid cancer
Observes outcomes of heat ablation and surgery in adults with low-risk thyroid cancer.
Plain-language title generated from the registry record
Registry title: The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma
Key facts
- Where
- Beijing, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06316895, who can take part
Where in China
- Chinese PLA General HospitalBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chinese PLA General Hospital
- Trial code
- NCT06316895
- Record updated
- 20 March 2026
- Original description
1. To evaluate the clinical outcomes of ultrasound-guided thermal ablation and thyroid surgery for the treatment of papillary thyroid carcinoma; 2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of papillary thyroid carcinoma;Read full original descriptionShow less
The Clinical Outcomes and Artificial Intelligence Prediction Model of Ultrasound-guided Thermal Ablation for the Treatment of Low-risk Papillary Thyroid Carcinoma
1. To evaluate the clinical outcomes of ultrasound-guided thermal ablation and thyroid surgery for the treatment of papillary thyroid carcinoma; 2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of papillary thyroid carcinoma;
Inclusion: patients age between 18 and 80 year old, both sex; papillary thyroid carcinoma confirmed by core-needle biopsy or fine-needle aspiration; the largest diameter ≤2.0 cm; no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, nech and chest CT; follow-up period ≥12 months,.
Exclusion: patients with convincing evidence of aggressive papillary thyroid carcinoma or other type of thyroid cancer by biopsy; history of neck radiation; history of thyroid surgery; coagulation disorder; serious heart, respiratory, liver, or renal failure; dysfunction of the vocal cord on the opposite side.